N-(Piperidin-4-yl)-6-(trifluoromethyl)pyridin-2-amine trihydrochloride, 1g

Thalidomide-O-PEG4-azide, 100mg

6-Fluoro-2-naphthoic acid methyl ester, 98%, 1g

Formamide, min. 99.5%, pa, ACS, 1 l, glass packaging

7,12-DIMETHYLBENZ[A]ANTHRACENE, 98%, 1g

4-(1-Oxo-2,3-butadien-1-yl)benzonitrile, 1g

2-Butyl-1H-imidazole, 95.0%, 1g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(pyridin-2-yl)propanoic acid, 95.0%, 10g

2-Benzoylpyrrole>98.0%(GC)25g

2,4-Bis(trifluoromethyl)benzaldehyde>97.0%(GC)5g

trans-Bis(acetato)bis[o-(di-o-tolylphosphino)benzyl]dipalladium(II)>95.0%(T)200mg

Methyl 4-benzyloxybenzoate, 98.0%, 1g

3-Bromo-1-methyl-1H-pyrazole-4-carbaldehyde, 98%, 500mg